Skip to main content

and
  1. Article

    Oral and Poster Papers Submitted for Presentation at the 5th Congress of the EUGMS “Geriatric Medicine in a Time of Generational Shift September 3–6, 2008 Copenhagen, Denmark

    A. Bonnerup Vind, H. E. Andersen, P. Schwarz in The Journal of Nutrition Health and Aging (2008)

  2. Article

    Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET in combination with microdialysis

    To determine the lumped constant (LC), which accounts for the differences in the transport and phosphorylation between [18F]-2-fluoro-2-deoxy-d-glucose ([18F]FDG) and glucose, for [18F]FDG in human adipose tissu...

    K. A. Virtanen, P. Peltoniemi, P. Marjamäki, M. Asola, L. Strindberg in Diabetologia (2001)

  3. No Access

    Article

    Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition

    Objective: Entacapone is a peripherally acting catechol O-methyltransferase (COMT) inhibitor used as an adjunct to each daily levodopa/dopa decarboxylase (DDC) inhibitor dose in the trea...

    J. Rouru, A. Gordin, R. Huupponen, S. Huhtala in European Journal of Clinical Pharmacology (1999)

  4. No Access

    Article

    A double-blind study of MPV-2213ad, a novel aromatase inhibitor, in healthy male subjects

    Objective: Novel aromatase inhibitors are developed with requirements of high potency and selectivity for the aromatase enzyme. The hormonal effects of a new, non-steroidal competitive i...

    O. Ahokoski, K. Irjala, S. Huhtala in European Journal of Clinical Pharmacology (1999)

  5. No Access

    Article

    Aqueous humour concentration and the intraocular pressure-lowering effect of topical betaxolol before cataract surgery

    Objective: The aim was to study the relationship between aqueous humour betaxolol concentration and intraocular pressure (IOP).

    E. Vainio-Jylhä, M.-L. Vuori, T. Kaila in European Journal of Clinical Pharmacology (1998)

  6. No Access

    Article

    Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine

    A pharmacokinetic study with 30 mg propiverine p.o. was performed in healthy volunteers (10 males, 6 females, age 36–56 years, body weight 55–100 kg, body height 162–184 cm, Broca index 0.96–1.19). 8 of them w...

    C. Müller, W. Siegmund, R. Huupponen in European Journal of Drug Metabolism and Ph… (1993)

  7. No Access

    Article

    The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide

    The pharmacokinetics and urinary metabolite pattern of a single oral dose of chlorpropamide 250 mg have been studied in 6 extensive and 5 poor metabolizers of debrisoquine. Ammonium chloride was given orally t...

    J. Kallio MD, R. Huupponen, K. Pyykkö in European Journal of Clinical Pharmacology (1990)

  8. No Access

    Article

    Prevalence of debrisoquine oxidation phenotypes in glaucoma patients

    The oxidation of debrisoquine, a sympatholytic antihypertensive agent, exhibits genetic polymorphism. The debrisoquine/4-OH-debrisoquine metabolic ratio (MR) separates the population to poor (PM, MR>12.6) and ...

    L. Salminen, R. Lindberg, H. -R. Toivari, R. Huupponen in International Ophthalmology (1989)

  9. No Access

    Article

    Effect of guar gum on glipizide absorption in man

    The effect of 4.75 g guar gum, a fibre preparation, on the absorption of 2.5 mg glipizide has been studied in 10 healthy volunteers given a standard breakfast. Three different experimental protocols were used:...

    R. Huupponen, S. Karhuvaara, P. Seppälä in European Journal of Clinical Pharmacology (1985)

  10. No Access

    Article

    Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man

    The effect of guar gum on the absorption of digoxin and phenoxymethyl penicillin was studied in a double blind study in 10 healthy volunteers. Guar gum reduced serum digoxin concentration during the early abso...

    R. Huupponen, P. Seppälä, E. Iisalo in European Journal of Clinical Pharmacology (1984)

  11. Article

    Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush

    The value and reproducibility of the chlorpropamide-alcohol flush (CPAF) have been questioned, and objective measures of the test are required. Recording of facial skin temperature, measurement of chlorpropami...

    L. Groop, C. J. P. Eriksson, R. Huupponen, R. Ylikahri, R. Pelkonen in Diabetologia (1984)